Business

FendX Announces Share Issuance Pursuant to IP License Agreement

Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, announces it has completed the issuance of common shares as consideration under the exclusive intellectual property license agreement (the "License Agreement") entered into with Scott Smith and US BioSolutions LLC previously announced on April 24, 2025, pursu

articleFendx Technologies, Inc.May 5, 20253/company/fendx-technologies-inc/news/fendx-announces-share-issuance-pursuant-000000977
FendX Announces Share Issuance Pursuant to IP License Agreement

About this update from Fendx Technologies, Inc.

[{"type":"text","content":"Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection coatings to reduce the spread of pathogens, announces it has completed the issuance of common shares as consideration under the exclusive intellectual property license agreement (the "License Agreement") entered into with Scott Smith and US BioSolutions LLC previously announced on April 24, 2025, pursuant to which FendX issued 1,000,000 common shares at a deemed price of $0.10 per share to Mr. Smith. The shares issued are subject to a Canadian hold period expiring four months and one day from the date of issuance as well as a United States hold period, in accordance with applicable securities laws.","length":832,"tagName":"p"},{"type":"text","content":"Pursuant to the License Agreement, the Company acquired an exclusive license to three patent applications from Mr. Smith related to the use of a sponge made from Open-Cell foam to be supplied from US BioSolutions in cleaning surfaces and for use of the sponge as a future wound care drug delivery device, as well as the licensed trademark, BioFoam® from US BioSolutions. In addition, the Company also entered a supply agreement (the "Supply Agreement") with US BioSolutions where US BioSolutions would supply the Company with bulk rolls of Open-Cell foam, manufactured using their proprietary manufacturing trade-secrets and know-how, which FendX can exclusively use to create a line of eco-friendly sponge products for sale and distribution in consumer, retail and other commercial cleaning markets.","length":810,"tagName":"p"},{"type":"text","content":"About FendX Technologies Inc.FendX is a Canada-based nanotechnology company focused on developing products to make people's lives safer by reducing the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP™ film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by r...

More updates from Fendx Technologies, Inc.

FendX Technologies Inc.The Companynanotechnologysupply agreementScott Smithintellectual property licenseFendX Technologies IncOpen-Cell foam